Search for: "In re Transkaryotic Therapies, Inc." Results 1 - 20 of 22
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2007, 7:26 am
More on Appraisal Rights and Transkaryotic Therapies In response to last week's blog on Chancellor Chandler's opinion in In re: Appraisal of Transkaryotic Therapies, Inc., an anonymous member weighed in: "By describing DTC as essentially a black box stuffed with... [read post]
10 May 2007, 7:03 am
Appraisal Rights: Delaware Chancellor Weighs In From Travis Laster: Last week, in In re: Appraisal of Transkaryotic Therapies, Inc., Chancellor Chandler of the Delaware Court of Chancery addressed a technical issue under the appraisal statute that has important implications for... [read post]
2 May 2007, 1:06 pm
In re Appraisal of Transkaryotic Therapies Inc., C.A. 1554-CC (May 2, 2007). [read post]
25 Jun 2008, 12:03 pm
Duty Of Disclosure: Delaware Chancellor Further Limits Availability of Damages From Travis Laster: Last week, Delaware Chancellor Chandler - in In re Transkaryotic Therapies, Inc. - granted summary judgment in favor of three directors who were alleged to have breached their fiduciary duties by supporting and voting in favor of the acquisition of Transkaryotic Therapies by Shire Pharmaceuticals. [read post]
16 Aug 2006, 12:40 pm
(Now Aventis) and Transkaryotic Therapies, Inc., (05-1157), the Court of Appeals for the Federal Circuit affirmed a District Court's decision that Transkaryotic Therapies Inc. [read post]
The findings follow the analysis applied in In Re Appraisal of Transkaryotic Therapies, Inc., a 2007 case which preceded an amendment to Section 262(e) later that year permitting beneficial owners to petition for appraisal in their own name. [read post]
3 Jan 2009, 5:15 am
#3     In re Transkaryotic Therapies, Inc., 954 A.2d 346 (Del. [read post]
22 Jul 2008, 12:27 pm
Duty Of Disclosure: Delaware Chancellor Further Limits Availability of Damages From Travis Laster: Recently, Delaware Chancellor Chandler - in In re Transkaryotic Therapies, Inc. - granted summary judgment in favor of three directors who were alleged to have breached their fiduciary duties by supporting and voting in favor of the acquisition of Transkaryotic Therapies by Shire Pharmaceuticals. [read post]
5 Feb 2016, 8:25 am by Lawrence B. Ebert
Transkaryotic Therapies, Inc., 346 F.3d 1094 (Fed. [read post]